Ozmosi | Azimilide Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Azimilide

Alternative Names: azimilide
Clinical Status: Inactive
Latest Update: 2017-02-01
Latest Update Note: Clinical Trial Update

Product Description

Azimilide is an investigational class III agent with electrophysiological effects on the repolarization phase of the cardiac action potential that are similar to amiodarone.  (Sourced from: https://www.ahajournals.org/doi/10.1161/01.cir.0000151357.36405.72)

Mechanisms of Action: Potassium Channel Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AbbVie
Company Location: Eastern America
Company Founding Year: 2013
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Tachycardia, Ventricular|Ventricular Fibrillation|Other|Atrial Fibrillation|Cardiac Arrhythmias

Phase 2: Heart Failure

Phase 1: Healthy Volunteers

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT00318838

NCT00318838

P1

Completed

Healthy Volunteers

2006-05-01

2019-03-21

Treatments

NCT00752596

NCT00752596

P2

Completed

Heart Failure

2006-07-01

2019-03-18

Treatments

2011-004376-11

2011-004376-11

P3

Terminated

Unknown

2014-11-15

2025-07-05

Treatments

NCT01464476

SHIELD-2

P3

Terminated

Cardiac Arrhythmias

2013-05-01

2019-03-19

Treatments

NCT00751738

NCT00751738

P3

Completed

Other

2005-10-01

2019-03-18

Treatments

NCT00035490

NCT00035490

P3

Completed

Tachycardia, Ventricular|Ventricular Fibrillation

2004-04-01

2019-03-21

NCT00035464

NCT00035464

P3

Completed

Atrial Fibrillation

2004-01-01

2019-03-21

Treatments

NCT00035477

NCT00035477

P3

Completed

Atrial Fibrillation

2003-10-01

2019-03-21

NCT00035451

NCT00035451

P3

Completed

Atrial Fibrillation

2003-06-01

2019-03-21

Treatments

Recent News Events

Date

Type

Title